Kedrion Biopharma
Por um escritor misterioso
Descrição
Kedrion Biopharma is a biopharmaceutical company that collects and fractionates blood plasma to produce and distribute worldwide plasma-derived therapies for use in treating and preventing rare and serious diseases and conditions.
In 2022, Kedrion joined forces with BPL (Bio Products Laboratory). Based in the United Kingdom, BPL has over 60 years of experience in the supply of high-quality plasma-derived medicines to treat rare diseases.
Kedrion distributes its products in over 100 countries around the world. We have plants in Italy, Hungary, UK and North America, and plasma collection centers in the US and in the Czech Republic. With these figures we are the world’s 5th top player in the field of plasma-derived products.
Our goal is to build a diverse and professional workforce, providing job opportunities for talented external candidates as well as internal employees who aim to grow with us.
Because our work includes so many interests and skills – from Research to Sales; Plasma Collection to Production – there are abundant possibilities for learning and growth.
Kedrion builds bridges: from donors to patients, from plasma to therapies, from challenge to hope.
First Patient Treated in KIDCARES10, Kedrion Biopharma Pediatric
Jeringa rellena Kedrion Biopharma Rhogam Plus con escudo de
Kedrion Biopharma
KEDPLASMA PALMVIEW - 207 W Palma Vista Dr, Palmview, Texas - Blood
Kedrion Biopharma - Northmarq
BPL & Kedrion – Jamieson
Anekant Pharma Kedrion Products
Covid-19: Kedrion Biopharma e Columbia University unite per una
Kedrion Biopharma redeems €200m of its notes that fall due in 2022
Kedrion Biopharma - USA
Kedrion Biopharma - USA
Transport of plasma in Italy goes green with Kedrion - Kedrion
Kedrion Biopharma Inc. company overview, insights, and reviews
MAESTrO: Kedrion Biopharma and Kamada receive FDA approval of
de
por adulto (o preço varia de acordo com o tamanho do grupo)